Search Results for: NKTR
The top analyst upgrades, downgrades and initiations seen on Tuesday include Carnival, Facebook, Freeport-McMoRan, Motorola Solutions and Procter & Gamble.
Published:
Last Updated:
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology NUVELO INC NEW [NUVO] +24.92% NEOSE TECH INC [NTEC] +20.67% CARDIOVASCULAR BIOTH [CVBT.OB] +18.18% CV THERAPEUTICS I [CVTX]...
Published:
by H.S. AyoubBioHealth Investor.com Buffett Missed These Two… Warren Buffett loves dividend stocks, and has stuffed Berkshire with some of his favorites. But he overlooked two dividend legends...
Published:
Nektar Therapeutics plans to price 13 million shares at $13.50 for a secondary offering valued up to almost $202 million.
Published:
Last Updated:
by H.S. AyoubBioHealth Investor.com Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored) Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it...
Published:
On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. These four stocks that could see the highest amount of share count buying.
Published:
The top analyst upgrades, downgrades and initiations seen on Monday include AK Steel, Amazon.com, AngloGold Ashanti, Bank of America, General Electric, Walt Disney and Xilinx.
Published:
Last Updated:
With 2017 nearing an end, it is important to consider just what has happened. 24/7 Wall St. has screened 50 stocks that have risen 100% or more (some far more) in 2017.
Published:
Last Updated:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Published:
The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings in the First Trust Biotechnology ETF.
Published:
Monday's additional top analyst upgrades and downgrades were on Coinbase Global, Global Blood Therapeutics, Grab, Leslie’s, Nektar Therapeutics, Park Hotels & Resorts, Rocket Companies and Roku.
Published:
Wednesday afternoon's top analyst upgrades and downgrades included Bumble, Coupang, Foot Locker, Gap, Match, Nektar Therapeutics, Paychex, Signify Health and Stitch Fix.
Published:
With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little.
Published:
Last Updated:
Monday’s additional top analyst upgrades and downgrades included Aptiv, BioCryst Pharmaceuticals, CSX, Gap, Nektar Therapeutics, Progressive, Peloton Interactive, Sirius XM and United Airlines.
Published:
The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have gleaned some interesting morsels that could be huge as the year wears on.
Published: